Eyebot

Boston, United States

Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care.

$20.0M raised

Aug 2025

Series A

Top Investors

National Science FoundationGeneral CatalystVillage GlobalAlleyCorpBaukunst

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eyebot raised?

Eyebot has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.

Who are Eyebot's investors?

Eyebot's investors include National Science Foundation, General Catalyst, Village Global, AlleyCorp, Baukunst.

Where is Eyebot headquartered?

Eyebot is headquartered in Boston, United States.

What does Eyebot do?

Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care.

What stage is Eyebot at?

Eyebot is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 26, 2025.

MLA

"Eyebot — Funding & Investors." VCBacked, August 26, 2025, https://www.vcbacked.co/company/eyebot. Accessed June 4, 2026.

APA

VCBacked. (2025). Eyebot — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/eyebot

Wikipedia (cite web)

{{cite web |title=Eyebot — Funding & Investors |url=https://www.vcbacked.co/company/eyebot |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 26, 2025.